Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

172 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
Kris MG, Natale RB, Herbst RS, Lynch TJ Jr, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H, Sandler A, Albain KS, Cella D, Wolf MK, Averbuch SD, Ochs JJ, Kay AC. Kris MG, et al. Among authors: albain ks. JAMA. 2003 Oct 22;290(16):2149-58. doi: 10.1001/jama.290.16.2149. JAMA. 2003. PMID: 14570950 Clinical Trial.
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, et al. Albain KS, et al. J Clin Oncol. 1995 Aug;13(8):1880-92. doi: 10.1200/JCO.1995.13.8.1880. J Clin Oncol. 1995. PMID: 7636530 Clinical Trial.
Induction treatment for resectable non-small-cell lung cancer.
Perry MC, Deslauriers J, Albain KS, Choi NC, Depierre A, Johnston MR, Lacquet LK, Payne DG, Putnam JB, Sculier JP, Shepherd FA. Perry MC, et al. Among authors: albain ks. Lung Cancer. 1997 Jun;17 Suppl 1:S15-8. doi: 10.1016/s0169-5002(97)00038-x. Lung Cancer. 1997. PMID: 9213297 Review. No abstract available.
172 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page